drugset / Trial / NCT06332287
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis
NaSingle-groupOpen-labelTreatment
Summary
To observe the efficacy of Trilaciclib combined with lateral ventricular chemotherapy in the treatment of non-small cell lung cancer with leptomeningeal metastasis。
Timeline
- Start
- 2023-05-01
- Primary completion
- 2024-11-01
- Completion
- 2025-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trilaciclib | Unknown | 240 mg/m2 | — |
| Background | Pemetrexed | Small molecule | 30 mg | — |